Award
National Cancer Institute 1R35CA305347-01
Overcoming Resistance to Targeted Therapy in Breast Cancer
Recipient
Sloan-Kettering Inst Can Research
Award Amount
$1,056,000.00
Ceiling
$1,056,000.00
Awarded
August 19, 2025
Identifier
1R35CA305347-01
Research project funded by the National Cancer Institute to study and overcome resistance to targeted breast cancer therapies, conducted at Sloan-Kettering Institute with an award of $1,056,000.
Description
This project aims to elucidate mechanisms of resistance to targeted therapies in breast cancer and develop curative approaches. It involves research at the Sloan-Kettering Institute, funded by the National Cancer Institute, with a total award amount of $1,056,000 for the fiscal year 2025. The project focuses on understanding genetic and cellular mechanisms underlying therapy resistance and response.